CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Deinove SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Deinove SA
Cap Sigma / ZAC Euromedecine II
1682 rue de la Valsiere
Phone: +33 448190100p:+33 448190100 GRABELS, 34790  France Fax: +33 499232450f:+33 499232450

Placed under Receivership on 10/28/2022
On 10/28/2022, Deinove SA filed a Declaration of Cessation of Payments ("déclaration de cessation des paiements") and a Request for Receivership Proceedings (“procédure de redressement judiciaire”) of the Company with the Montpellier Commercial Court.
On 11/7/2022, the Montpellier Commercial Court opened Receivership Proceedings for Deinove SA. The Court appointed Maitre Jean-François Blanc as the Receiver of the Company.
On 1/23/2023, Deinove SA's Receivership Proceeding was converted to one of Judicial Liquidation by the Montpellier Commercial Court. Christine Dauverchain was appointed as the Judicial Liquidator.
This company is no longer actively traded on any major stock exchange.

Business Summary
Deinove SA is a France-based company active in the renewable fuels sector. It specializes in the development and commercial exploitation of processes for production of biofuels and other compounds of industrial or pharmaceutical value. The processes developed by Deinove use the natural properties of Deinococcus bacteria. The green chemistry process includes the production of organic acids, such as succinic, lactic, fumaric and butyric acids used in the petrochemical, pharmaceutical, cosmetics and food industries. In addition, the Company is engaged in the production of antibiotics and antifungal agents. Deinove SA operates with such industrial companies as Tereos, CNRS, VTT, BENP-Lillebonne and Nosopharm, among others. The Company's main shareholder is Fonds Truffle Capital. It operates through DEINOBIOTICS and Deinobiotics SAS, among others.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202212/31/2021Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board CharlesWoler 1/8/2021 1/20/2017
Chief Executive Officer AlexisRideau 1/8/2021 5/1/2020
Administrative & Financial Director, Investor Relations and Financial Communication MarioAlcaraz 1/1/2020 1/1/2020
8 additional Officers and Directors records available in full report.

Business Names
Business Name
ALDEI
Biovertis AG
Deinobiotics SAS
Morphochem AG für kombinatorische Chemie

General Information
Number of Employees: 44 (As of 6/30/2022)
Outstanding Shares: 34,345,891 (As of 6/30/2022)
Stock Exchange: EPA
Fax Number: +33 499232450


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, February 27, 2024